sublingual tirzepatide Oral Pill: FDA-Approved Options Tirzepatide oral vs injection: which
Description
Most clinicians recommend stopping the medication at least two months before trying for a baby
47 MOD-6031, a long-acting, pegylated molecule of oxyntomodulin, has been tested in a phase 1 single-blinded RCT (NCT02692781) on overweight or obese patients, but further investigations have not taken place
In children and adolescents: The same factors that limit the efficacy of BMI for adults can also apply to children and adolescents
The introduction of GLP-1 receptor agonists, such as semaglutide, may further complicate the clinical picture in this high-risk population
